APO Research
Talk to an analyst

APO RESEARCH · REPORT

SPECT and SPECT-CT

Using specialized detector crystals that emit light when hit by photons (radiation emanating from the body) we are able to plot their origin on a grid or matrix using intricate x- y- coordinate circuitry that ultimately allows us to reconstruct the physiological and pathological processes taking place in the body pictographically by coupling radioactive isotopes to specific drugs, chemicals and molecules and administering them.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Using specialized detector crystals that emit light when hit by photons (radiation emanating from the body) we are able to plot their origin on a grid or matrix using intricate x- y- coordinate circuitry that ultimately allows us to reconstruct the physiological and pathological processes taking place in the body pictographically by coupling radioactive isotopes to specific drugs, chemicals and molecules and administering them.

Selected research

Market Outlook & Growth Opportunities

Global SPECT and SPECT-CT Market Outlook and Growth Opportunities 2026

31 December 2025193 pages

Choose your research edition.

Industry ResearchSPECT and SPECT-CT Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal SPECT and SPECT-CT Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal SPECT and SPECT-CT Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SPECT and SPECT-CT Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal SPECT and SPECT-CT Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Using specialized detector crystals that emit light when hit by photons (radiation emanating from the body) we are able to plot their origin on a grid or matrix using intricate x- y- coordinate circuitry that ultimately allows us to reconstruct the physiological and pathological processes taking place in the body pictographically by coupling radioactive isotopes to specific drugs, chemicals and molecules and administering them.

GE healthcare is estimated to have a major share in the global market with 38%.

This report provides an overview of the global SPECT and SPECT-CT market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of SPECT and SPECT-CT and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents SPECT and SPECT-CT sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the SPECT and SPECT-CT market size, projected growth trends, production technologies, key applications, and end-use industries.

SPECT and SPECT-CT Segment by Company

GE Healthcare

Siemens Healthineers

Philips Healthcare

Mediso

Spectrum Dynamics

Bruker

SurgicEye

MIE

MILabs

SPECT and SPECT-CT Segment by Type

SPECT

SPECT-CT

SPECT and SPECT-CT Segment by Application

Oncology

Cardiology

Neurology

Other

SPECT and SPECT-CT Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global SPECT and SPECT-CT status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions SPECT and SPECT-CT market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify SPECT and SPECT-CT significant trends, drivers, influence factors in global and regions.

6. To analyze SPECT and SPECT-CT competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT and SPECT-CT market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SPECT and SPECT-CT and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT and SPECT-CT.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the SPECT and SPECT-CT market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global SPECT and SPECT-CT industry.

Chapter 3: Detailed analysis of SPECT and SPECT-CT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of SPECT and SPECT-CT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of SPECT and SPECT-CT in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. SPECT and SPECT-CT Industry Trends Table 2. SPECT and SPECT-CT Industry Drivers Table 3. SPECT and SPECT-CT Industry Opportunities and Challenges Table 4. SPECT and SPECT-CT Industry Restraints Table 5. Global SPECT and SPECT-CT Revenue by Company (US$ Million) & (2021-2026) Table 6. Global SPECT and SPECT-CT Revenue Share by Company (2021-2026) Table 7. Global SPECT and SPECT-CT Sales Volume by Company (Units) & (2021-2026) Table 8. Global SPECT and SPECT-CT Sales Volume Share by Company (2021-2026) Table 9. Global SPECT and SPECT-CT Average Price (USD/Unit) of Company (2021-2026) Table 10. Global SPECT and SPECT-CT Company Ranking, (2024-2026) & (USD Million) Table 11. Global SPECT and SPECT-CT Key Company Manufacturing Base & Headquarters Table 12. Global SPECT and SPECT-CT Company, Product Type & Application Table 13. Global SPECT and SPECT-CT Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global SPECT and SPECT-CT by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of SPECT Table 18. Significant Companies of SPECT-CT Table 19. Global SPECT and SPECT-CT Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global SPECT and SPECT-CT Sales Volume by Type (2021-2026) & (Units) Table 21. Global SPECT and SPECT-CT Sales Volume by Type (2027-2032) & (Units) Table 22. Global SPECT and SPECT-CT Sales Volume Share by Type (2021-2026) Table 23. Global SPECT and SPECT-CT Sales Volume Share by Type (2027-2032) Table 24. Global SPECT and SPECT-CT Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global SPECT and SPECT-CT Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global SPECT and SPECT-CT Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global SPECT and SPECT-CT Sales Value Share by Type (2021-2026) Table 28. Global SPECT and SPECT-CT Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oncology Table 30. Significant Companies of Cardiology Table 31. Significant Companies of Neurology Table 32. Significant Companies of Other Table 33. Global SPECT and SPECT-CT Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global SPECT and SPECT-CT Sales Volume by Application (2021-2026) & (Units) Table 35. Global SPECT and SPECT-CT Sales Volume by Application (2027-2032) & (Units) Table 36. Global SPECT and SPECT-CT Sales Volume Share by Application (2021-2026) Table 37. Global SPECT and SPECT-CT Sales Volume Share by Application (2027-2032) Table 38. Global SPECT and SPECT-CT Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global SPECT and SPECT-CT Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global SPECT and SPECT-CT Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global SPECT and SPECT-CT Sales Value Share by Application (2021-2026) Table 42. Global SPECT and SPECT-CT Sales Value Share by Application (2027-2032) Table 43. Global SPECT and SPECT-CT Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global SPECT and SPECT-CT Sales by Region (2021-2026) & (Units) Table 45. Global SPECT and SPECT-CT Sales Market Share by Region (2021-2026) Table 46. Global SPECT and SPECT-CT Sales by Region (2027-2032) & (Units) Table 47. Global SPECT and SPECT-CT Sales Market Share by Region (2027-2032) Table 48. Global SPECT and SPECT-CT Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global SPECT and SPECT-CT Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global SPECT and SPECT-CT Sales Value Share by Region (2021-2026) Table 51. Global SPECT and SPECT-CT Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global SPECT and SPECT-CT Sales Value Share by Region (2027-2032) Table 53. Global SPECT and SPECT-CT Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global SPECT and SPECT-CT Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global SPECT and SPECT-CT Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global SPECT and SPECT-CT Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global SPECT and SPECT-CT Sales by Country (2021-2026) & (Units) Table 58. Global SPECT and SPECT-CT Sales Market Share by Country (2021-2026) Table 59. Global SPECT and SPECT-CT Sales by Country (2027-2032) & (Units) Table 60. Global SPECT and SPECT-CT Sales Market Share by Country (2027-2032) Table 61. Global SPECT and SPECT-CT Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global SPECT and SPECT-CT Sales Value Market Share by Country (2021-2026) Table 63. Global SPECT and SPECT-CT Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global SPECT and SPECT-CT Sales Value Market Share by Country (2027-2032) Table 65. GE Healthcare Company Information Table 66. GE Healthcare Business Overview Table 67. GE Healthcare SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. GE Healthcare SPECT and SPECT-CT Product Portfolio Table 69. GE Healthcare Recent Development Table 70. Siemens Healthineers Company Information Table 71. Siemens Healthineers Business Overview Table 72. Siemens Healthineers SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Siemens Healthineers SPECT and SPECT-CT Product Portfolio Table 74. Siemens Healthineers Recent Development Table 75. Philips Healthcare Company Information Table 76. Philips Healthcare Business Overview Table 77. Philips Healthcare SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Philips Healthcare SPECT and SPECT-CT Product Portfolio Table 79. Philips Healthcare Recent Development Table 80. Mediso Company Information Table 81. Mediso Business Overview Table 82. Mediso SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Mediso SPECT and SPECT-CT Product Portfolio Table 84. Mediso Recent Development Table 85. Spectrum Dynamics Company Information Table 86. Spectrum Dynamics Business Overview Table 87. Spectrum Dynamics SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Spectrum Dynamics SPECT and SPECT-CT Product Portfolio Table 89. Spectrum Dynamics Recent Development Table 90. Bruker Company Information Table 91. Bruker Business Overview Table 92. Bruker SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Bruker SPECT and SPECT-CT Product Portfolio Table 94. Bruker Recent Development Table 95. SurgicEye Company Information Table 96. SurgicEye Business Overview Table 97. SurgicEye SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. SurgicEye SPECT and SPECT-CT Product Portfolio Table 99. SurgicEye Recent Development Table 100. MIE Company Information Table 101. MIE Business Overview Table 102. MIE SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. MIE SPECT and SPECT-CT Product Portfolio Table 104. MIE Recent Development Table 105. MILabs Company Information Table 106. MILabs Business Overview Table 107. MILabs SPECT and SPECT-CT Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. MILabs SPECT and SPECT-CT Product Portfolio Table 109. MILabs Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. SPECT and SPECT-CT Distributors List Table 113. SPECT and SPECT-CT Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. SPECT and SPECT-CT Product Image Figure 2. Global SPECT and SPECT-CT Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SPECT and SPECT-CT Sales Value (2021-2032) & (US$ Million) Figure 4. Global SPECT and SPECT-CT Sales (2021-2032) & (Units) Figure 5. Global SPECT and SPECT-CT Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global SPECT and SPECT-CT Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. SPECT Image Figure 10. SPECT-CT Image Figure 11. Global SPECT and SPECT-CT Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global SPECT and SPECT-CT Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global SPECT and SPECT-CT Sales Volume Share by Type (2021-2032) Figure 14. Global SPECT and SPECT-CT Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global SPECT and SPECT-CT Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global SPECT and SPECT-CT Sales Value Share by Type (2021-2032) Figure 17. Oncology Image Figure 18. Cardiology Image Figure 19. Neurology Image Figure 20. Other Image Figure 21. Global SPECT and SPECT-CT Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global SPECT and SPECT-CT Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global SPECT and SPECT-CT Sales Volume Share by Application (2021-2032) Figure 24. Global SPECT and SPECT-CT Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global SPECT and SPECT-CT Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global SPECT and SPECT-CT Sales Value Share by Application (2021-2032) Figure 27. Global SPECT and SPECT-CT Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global SPECT and SPECT-CT Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global SPECT and SPECT-CT Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global SPECT and SPECT-CT Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America SPECT and SPECT-CT Sales Value (2021-2032) & (US$ Million) Figure 32. North America SPECT and SPECT-CT Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe SPECT and SPECT-CT Sales Value (2021-2032) & (US$ Million) Figure 34. Europe SPECT and SPECT-CT Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific SPECT and SPECT-CT Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific SPECT and SPECT-CT Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America SPECT and SPECT-CT Sales Value (2021-2032) & (US$ Million) Figure 38. South America SPECT and SPECT-CT Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa SPECT and SPECT-CT Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa SPECT and SPECT-CT Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt SPECT and SPECT-CT Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. SPECT and SPECT-CT Value Chain Figure 126. Manufacturing Cost Structure Figure 127. SPECT and SPECT-CT Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • SPECT
  • SPECT-CT
Applications
  • Oncology
  • Cardiology
  • Neurology
  • Other
Companies covered
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Mediso
  • Spectrum Dynamics
  • Bruker
  • SurgicEye
  • MIE
  • MILabs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global SPECT and SPECT-CT Sales Value (2021-2032)
  4. 1.2.2 Global SPECT and SPECT-CT Sales Volume (2021-2032)
  5. 1.2.3 Global SPECT and SPECT-CT Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 SPECT and SPECT-CT Market Dynamics
  1. 2.1 SPECT and SPECT-CT Industry Trends
  2. 2.2 SPECT and SPECT-CT Industry Drivers
  3. 2.3 SPECT and SPECT-CT Industry Opportunities and Challenges
  4. 2.4 SPECT and SPECT-CT Industry Restraints
3 SPECT and SPECT-CT Market by Company
  1. 3.1 Global SPECT and SPECT-CT Company Revenue Ranking in 2025
  2. 3.2 Global SPECT and SPECT-CT Revenue by Company (2021-2026)
  3. 3.3 Global SPECT and SPECT-CT Sales Volume by Company (2021-2026)
  4. 3.4 Global SPECT and SPECT-CT Average Price by Company (2021-2026)
  5. 3.5 Global SPECT and SPECT-CT Company Ranking (2024-2026)
  6. 3.6 Global SPECT and SPECT-CT Company Manufacturing Base and Headquarters
  7. 3.7 Global SPECT and SPECT-CT Company Product Type and Application
  8. 3.8 Global SPECT and SPECT-CT Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global SPECT and SPECT-CT Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 SPECT and SPECT-CT Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 SPECT and SPECT-CT Market by Type
  1. 4.1 SPECT and SPECT-CT Type Introduction
  2. 4.1.1 SPECT
  3. 4.1.2 SPECT-CT
  4. 4.2 Global SPECT and SPECT-CT Sales Volume by Type
  5. 4.2.1 Global SPECT and SPECT-CT Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global SPECT and SPECT-CT Sales Volume by Type (2021-2032)
  7. 4.2.3 Global SPECT and SPECT-CT Sales Volume Share by Type (2021-2032)
  8. 4.3 Global SPECT and SPECT-CT Sales Value by Type
  9. 4.3.1 Global SPECT and SPECT-CT Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global SPECT and SPECT-CT Sales Value by Type (2021-2032)
  11. 4.3.3 Global SPECT and SPECT-CT Sales Value Share by Type (2021-2032)
5 SPECT and SPECT-CT Market by Application
  1. 5.1 SPECT and SPECT-CT Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Neurology
  5. 5.1.4 Other
  6. 5.2 Global SPECT and SPECT-CT Sales Volume by Application
  7. 5.2.1 Global SPECT and SPECT-CT Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global SPECT and SPECT-CT Sales Volume by Application (2021-2032)
  9. 5.2.3 Global SPECT and SPECT-CT Sales Volume Share by Application (2021-2032)
  10. 5.3 Global SPECT and SPECT-CT Sales Value by Application
  11. 5.3.1 Global SPECT and SPECT-CT Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global SPECT and SPECT-CT Sales Value by Application (2021-2032)
  13. 5.3.3 Global SPECT and SPECT-CT Sales Value Share by Application (2021-2032)
6 SPECT and SPECT-CT Regional Sales and Value Analysis
  1. 6.1 Global SPECT and SPECT-CT Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global SPECT and SPECT-CT Sales by Region (2021-2032)
  3. 6.2.1 Global SPECT and SPECT-CT Sales by Region: 2021-2026
  4. 6.2.2 Global SPECT and SPECT-CT Sales by Region (2027-2032)
  5. 6.3 Global SPECT and SPECT-CT Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global SPECT and SPECT-CT Sales Value by Region (2021-2032)
  7. 6.4.1 Global SPECT and SPECT-CT Sales Value by Region: 2021-2026
  8. 6.4.2 Global SPECT and SPECT-CT Sales Value by Region (2027-2032)
  9. 6.5 Global SPECT and SPECT-CT Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America SPECT and SPECT-CT Sales Value (2021-2032)
  12. 6.6.2 North America SPECT and SPECT-CT Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe SPECT and SPECT-CT Sales Value (2021-2032)
  15. 6.7.2 Europe SPECT and SPECT-CT Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific SPECT and SPECT-CT Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific SPECT and SPECT-CT Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America SPECT and SPECT-CT Sales Value (2021-2032)
  21. 6.9.2 South America SPECT and SPECT-CT Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa SPECT and SPECT-CT Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa SPECT and SPECT-CT Sales Value Share by Country, 2025 VS 2032
7 SPECT and SPECT-CT Country-level Sales and Value Analysis
  1. 7.1 Global SPECT and SPECT-CT Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global SPECT and SPECT-CT Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global SPECT and SPECT-CT Sales by Country (2021-2032)
  4. 7.3.1 Global SPECT and SPECT-CT Sales by Country (2021-2026)
  5. 7.3.2 Global SPECT and SPECT-CT Sales by Country (2027-2032)
  6. 7.4 Global SPECT and SPECT-CT Sales Value by Country (2021-2032)
  7. 7.4.1 Global SPECT and SPECT-CT Sales Value by Country (2021-2026)
  8. 7.4.2 Global SPECT and SPECT-CT Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt SPECT and SPECT-CT Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt SPECT and SPECT-CT Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt SPECT and SPECT-CT Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE Healthcare
  2. 8.1.1 GE Healthcare Company Information
  3. 8.1.2 GE Healthcare Business Overview
  4. 8.1.3 GE Healthcare SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GE Healthcare SPECT and SPECT-CT Product Portfolio
  6. 8.1.5 GE Healthcare Recent Developments
  7. 8.2 Siemens Healthineers
  8. 8.2.1 Siemens Healthineers Company Information
  9. 8.2.2 Siemens Healthineers Business Overview
  10. 8.2.3 Siemens Healthineers SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthineers SPECT and SPECT-CT Product Portfolio
  12. 8.2.5 Siemens Healthineers Recent Developments
  13. 8.3 Philips Healthcare
  14. 8.3.1 Philips Healthcare Company Information
  15. 8.3.2 Philips Healthcare Business Overview
  16. 8.3.3 Philips Healthcare SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Philips Healthcare SPECT and SPECT-CT Product Portfolio
  18. 8.3.5 Philips Healthcare Recent Developments
  19. 8.4 Mediso
  20. 8.4.1 Mediso Company Information
  21. 8.4.2 Mediso Business Overview
  22. 8.4.3 Mediso SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mediso SPECT and SPECT-CT Product Portfolio
  24. 8.4.5 Mediso Recent Developments
  25. 8.5 Spectrum Dynamics
  26. 8.5.1 Spectrum Dynamics Company Information
  27. 8.5.2 Spectrum Dynamics Business Overview
  28. 8.5.3 Spectrum Dynamics SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Spectrum Dynamics SPECT and SPECT-CT Product Portfolio
  30. 8.5.5 Spectrum Dynamics Recent Developments
  31. 8.6 Bruker
  32. 8.6.1 Bruker Company Information
  33. 8.6.2 Bruker Business Overview
  34. 8.6.3 Bruker SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bruker SPECT and SPECT-CT Product Portfolio
  36. 8.6.5 Bruker Recent Developments
  37. 8.7 SurgicEye
  38. 8.7.1 SurgicEye Company Information
  39. 8.7.2 SurgicEye Business Overview
  40. 8.7.3 SurgicEye SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SurgicEye SPECT and SPECT-CT Product Portfolio
  42. 8.7.5 SurgicEye Recent Developments
  43. 8.8 MIE
  44. 8.8.1 MIE Company Information
  45. 8.8.2 MIE Business Overview
  46. 8.8.3 MIE SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MIE SPECT and SPECT-CT Product Portfolio
  48. 8.8.5 MIE Recent Developments
  49. 8.9 MILabs
  50. 8.9.1 MILabs Company Information
  51. 8.9.2 MILabs Business Overview
  52. 8.9.3 MILabs SPECT and SPECT-CT Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 MILabs SPECT and SPECT-CT Product Portfolio
  54. 8.9.5 MILabs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 SPECT and SPECT-CT Value Chain Analysis
  2. 9.1.1 SPECT and SPECT-CT Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 SPECT and SPECT-CT Sales Mode & Process
  6. 9.2 SPECT and SPECT-CT Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 SPECT and SPECT-CT Distributors
  9. 9.2.3 SPECT and SPECT-CT Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst